[
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "f261c5b7-512c-4ac9-bc94-dc99607befa7.pdf",
            "originalText": "HAL Id: hal-04036382\nhttps://hal.science/hal-04036382\nSubmitted on 23 Apr 2023\nHAL is a multi-disciplinary open access\narchive for the deposit and dissemination of sci-\nentific research documents, whether they are pub-\nlished or not. The documents may come from\nteaching and research institutions in F rance or\nabroad, or from public or private research centers.L’archive ouverte pluridisciplinaire HAL , est\ndestinée au dépôt et à la diffusion de documents\nscientifiques de niveau recherche, publiés ou non,\némanant des établissements d’enseignement et de\nrecherche français ou étrangers, des laboratoires\npublics ou privés.\nDeep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in\nParkinson Disease\nJanan Arslan, Daniel Racoceanu, Kurt K Benke\nT o cite this version:\nJanan Arslan, Daniel Racoceanu, Kurt K Benke. Deep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in Parkinson Disease. JAMA Ophthalmology ,\n2023, 141 (3), pp.240-241. ￿10.1001/jamaophthalmol.2022.6036￿. ￿hal-04036382￿",
            "page": 0
        },
        "id": "1548"
    },
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "f261c5b7-512c-4ac9-bc94-dc99607befa7.pdf",
            "originalText": "HAL Id: hal-04036382\nhttps://hal.science/hal-04036382\nSubmitted on 23 Apr 2023\nHAL is a multi-disciplinary open access\narchive for the deposit and dissemination of sci-\nentific research documents, whether they are pub-\nlished or not. The documents may come from\nteaching and research institutions in F rance or\nabroad, or from public or private research centers.L’archive ouverte pluridisciplinaire HAL , est\ndestinée au dépôt et à la diffusion de documents\nscientifiques de niveau recherche, publiés ou non,\némanant des établissements d’enseignement et de\nrecherche français ou étrangers, des laboratoires\npublics ou privés.\nDeep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in\nParkinson Disease\nJanan Arslan, Daniel Racoceanu, Kurt K Benke\nT o cite this version:\nJanan Arslan, Daniel Racoceanu, Kurt K Benke. Deep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in Parkinson Disease. JAMA Ophthalmology ,\n2023, 141 (15), pp.240-241. ￿10.1001/jamaophthalmol.2022.6036￿. ￿hal-04036382￿",
            "page": 1
        },
        "id": "1558"
    },
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "f261c5b7-512c-4ac9-bc94-dc99607befa7.pdf",
            "originalText": "Invited Commentary\nDeep Learning Using Images of the Retina for Assessment of Severity of\nNeurological Dysfunction in Parkinson Disease\nJanan Arslan, MSc, MBiostat, PhD; Daniel Racoceanu, PhD; Kurt K. Benke, PhD\nThe deep learning (DL) approach is a recent development in\nresearchontheautomationofmedicaldiagnosticsusingma-\nchinelearning.Thistypeofstatisticallearningisnotbasedon\nbiophysical(mechanistic)modelsbutontraining(forparam-\neter estimation) using a\nsample of population data.\nThereareissuesaboutrobust-\nnessinperformancewhentestingonnewdatasetsinuncon-\ntrolledconditionsseparatefromvalidationexperiments.The\nuseofDLindiagnosticmodelinghasbeendemonstratedinre-\ncentyearswithveryencouragingresultsintheassessmentof\ndiabeticretinopathy,geographicatrophyinage-relatedmacu-\nlardegeneration,andcardiovasculardiseasewhenusingim-\nagesoftheretina.1\nThestudybyAhnetal1inthisissueof JAMA Ophthalmol-\nogyprovidesinsightsandusefulinformationontheapplica-\ntion of DL to explore possible associations between changes\nin the retina and brain function. The reported work is inter-\nestingasitexplorestheuseofDLapproachesforassessment\nofcognitivefunctionscoresfordiseaseseverityinthecaseof\nParkinsondisease(PD),whichisprojectedtobeanincreasing\neconomicburden.2Inthestudy,fundusphotographswerecol-\nlectedfrom615participantswhowereoutpatientsattheneu-\nrologydepartmentofKangbukSamsungHospitalinSouthKo-\nrea(August2020toApril2021).Tocompensateforthetypically\nsmall sample sizes often encountered in ophthalmology re-\nsearch, the authors applied a range of image augmentation\ntechniques,whichincludedrandomrotationandrandomflip,\ntoincreasethesamplesize.\nFivecommonconvolutionalneuralnetwork(CNN)mod-\nelswereinvestigatedtopredicttheHoehnandYahrScale(H-Y)\nandUnifiedParkinson’sDiseaseRatingScalepartIII(UPDRS)\nscores for PD,3,4with the training based on fundus photo-\ngraphs and patient demographic characteristics. The study\nechoed other works that have investigated the idea that\nchangesmanifestedintheretinamayprovideindicatorsofneu-\nrological impairment due to PD.5The prospective case-\ncontrolhospital-basedstudyrevealedthat,fortheinternalvali-\ndationdata,theDLsystemhadhighsensitivitythatwasabove\n80%forboththeH–YandUPDRSscores.Thespecificityranged\nfrom66%to67%forH-YandUPDRSscores.Fortheexternal\nvalidationdata,thesensitivityandspecificitywere70.73%and\n66.66%.Theareaunderthereceiveroperatingcharacteristic\ncurvewas0.67andaccuracywas70.5%.\nAnadvantageofthismethodforseverityassessmentisthat\nitisnoninvasiveandbasedonreadilyavailablefundusretina\nimages,ratherthanusingimagesofthebrain,suchasradio-\nlogicalimageslikecomputedtomographyandmagneticreso-\nnanceimagingscans.Comparatively,theseimagesarealittle\nmoreinvasiveandtimeconsumingintheiracquisition.Anad-\nditional salient feature of this study was that it suggests thepossibility of augmenting or even eventually replacing the 2\nstandard tests for severity of PD dysfunction, which are rat-\ning scales with a subjective component, with a more objec-\ntive approach that reduces risk and uncertainty in diagnosis\nand therefore improves reliability. An approach based on DL\nmaybeusedasafastscreeningmethodforcognitiveimpair-\nmentduringroutineeyeexaminations.Afeatureofthediag-\nnostic method is that finding an association between the al-\ngorithm prediction and the results for the 2 standard tests\nprovides a degree of “explainability.” This is because the DL\nalgorithmusedtodevelopthepredictivemodelproducesre-\nsultsthatareassociatedwithadiseaseseverityscale.Further-\nmore,",
            "page": 2
        },
        "id": "1567"
    },
    {
        "document": "Unified Parkinson’s Disease Rating Scale",
        "metadata": {
            "originalPdf": "f261c5b7-512c-4ac9-bc94-dc99607befa7.pdf",
            "originalText": "Invited Commentary\nDeep Learning Using Images of the Retina for Assessment of Severity of\nNeurological Dysfunction in Parkinson Disease\nJanan Arslan, MSc, MBiostat, PhD; Daniel Racoceanu, PhD; Kurt K. Benke, PhD\nThe deep learning (DL) approach is a recent development in\nresearchontheautomationofmedicaldiagnosticsusingma-\nchinelearning.Thistypeofstatisticallearningisnotbasedon\nbiophysical(mechanistic)modelsbutontraining(forparam-\neter estimation) using a\nsample of population data.\nThereareissuesaboutrobust-\nnessinperformancewhentestingonnewdatasetsinuncon-\ntrolledconditionsseparatefromvalidationexperiments.The\nuseofDLindiagnosticmodelinghasbeendemonstratedinre-\ncentyearswithveryencouragingresultsintheassessmentof\ndiabeticretinopathy,geographicatrophyinage-relatedmacu-\nlardegeneration,andcardiovasculardiseasewhenusingim-\nagesoftheretina.1\nThestudybyAhnetal1inthisissueof JAMA Ophthalmol-\nogyprovidesinsightsandusefulinformationontheapplica-\ntion of DL to explore possible associations between changes\nin the retina and brain function. The reported work is inter-\nestingasitexplorestheuseofDLapproachesforassessment\nofcognitivefunctionscoresfordiseaseseverityinthecaseof\nParkinsondisease(PD),whichisprojectedtobeanincreasing\neconomicburden.2Inthestudy,fundusphotographswerecol-\nlectedfrom615participantswhowereoutpatientsattheneu-\nrologydepartmentofKangbukSamsungHospitalinSouthKo-\nrea(August2020toApril2021).Tocompensateforthetypically\nsmall sample sizes often encountered in ophthalmology re-\nsearch, the authors applied a range of image augmentation\ntechniques,whichincludedrandomrotationandrandomflip,\ntoincreasethesamplesize.\nFivecommonconvolutionalneuralnetwork(CNN)mod-\nelswereinvestigatedtopredicttheHoehnandYahrScale(H-Y)\nandUnifiedParkinson’sDiseaseRatingScalepartIII(UPDRS)\nscores for PD,3,4with the training based on fundus photo-\ngraphs and patient demographic characteristics. The study\nechoed other works that have investigated the idea that\nchangesmanifestedintheretinamayprovideindicatorsofneu-\nrological impairment due to PD.5The prospective case-\ncontrolhospital-basedstudyrevealedthat,fortheinternalvali-\ndationdata,theDLsystemhadhighsensitivitythatwasabove\n80%forboththeH–YandUPDRSscores.Thespecificityranged\nfrom66%to67%forH-YandUPDRSscores.Fortheexternal\nvalidationdata,thesensitivityandspecificitywere70.73%and\n66.66%.Theareaunderthereceiveroperatingcharacteristic\ncurvewas0.67andaccuracywas70.5%.\nAnadvantageofthismethodforseverityassessmentisthat\nitisnoninvasiveandbasedonreadilyavailablefundusretina\nimages,ratherthanusingimagesofthebrain,suchasradio-\nlogicalimageslikecomputedtomographyandmagneticreso-\nnanceimagingscans.Comparatively,theseimagesarealittle\nmoreinvasiveandtimeconsumingintheiracquisition.Anad-\nditional salient feature of this study was that it suggests thepossibility of augmenting or even eventually replacing the 2\nstandard tests for severity of PD dysfunction, which are rat-\ning scales with a subjective component, with a more objec-\ntive approach that reduces risk and uncertainty in diagnosis\nand therefore improves reliability. An approach based on DL\nmaybeusedasafastscreeningmethodforcognitiveimpair-\nmentduringroutineeyeexaminations.Afeatureofthediag-\nnostic method is that finding an association between the al-\ngorithm prediction and the results for the 2 standard tests\nprovides a degree of “explainability.” This is because the DL\nalgorithmusedtodevelopthepredictivemodelproducesre-\nsultsthatareassociatedwithadiseaseseverityscale.Further-\nmore,",
            "page": 2
        },
        "id": "1569"
    },
    {
        "document": "International Parkinson Disease and Movement Disorder Society",
        "metadata": {
            "originalPdf": "03.Deep Learning, the Retina, and Parkinson Disease (COMMENT & RESPONSE).pdf",
            "originalText": "ents . 4th ed. American Academy\nof Pediatrics; 2017. doi: 10.1542/9781610020237\n2. Marsh-Tootle WL, Wall TC, Tootle JS, Person SD, Kristofco RE. Quantitative\npediatric vision screening in primary care settings in Alabama. Optom Vis Sci .\n2008;85(9):849-856. doi: 10.1097/OPX.0b013e318185282a3. Health Resources and Services Administration. Children with special health\ncare needs. NSCH Data Brief. July 2020. Accessed June 14, 2023. https://mchb.\nhrsa.gov/sites/default/files/mchb/programs-impact/nsch-cshcn-data-brief.pdf\n4. Ma X, Zhou Z, Yi H, et al. Effect of providing free glasses on children’s\neducational outcomes in China: cluster randomized controlled trial. BMJ. 2014;\n349:g5740. doi: 10.1136/bmj.g5740\n5. Muhammad M, Tumin D. Unmet needs for vision care among children with\ngaps in health insurance coverage. J AAPOS . 2022;26(2):63.e1-63.e4.\ndoi:10.1016/j.jaapos.2021.12.005\n6. US Department of Health and Human Services. Children’s health coverage\ntrends: gains in 2020-2022 reverse previous coverage losses. Accessed June 14.2023. https://aspe.hhs.gov/sites/default/files/documents/\n77d7cc41648a371e0b5128f0dec2470e/aspe-childrens-health-coverage.pdf .\nCOMMENT & RESPONSE\nDeep Learning, the Retina,\nand Parkinson Disease\nTo the Editor IreadwithinterestthearticlebyAhnetal1onthe\napplication of deep-learning algorithms to retinal photo-graphsinParkinsondisease(PD).Whileitisintriguingthatadeep-learningalgorithmcanpredictthepresenceandsever-ity of PD with 65% to 75% accuracy, the broader motivationandpracticalapplicationsforthisworkareunclear.\nThe authors\n1write that complex neurologic tests are\nrequired to diagnose PD, and therefore, new diagnostic testsare needed. This is true only insomuch as taking a historyand performing a neurologic examination are consideredcomplex. PD is a clinical diagnosis for which no imaging orlaboratory testing is required. Brain imaging is frequentlyincorporated into research studies but is not required for aclinical diagnosis according to diagnostic criteria from theInternational Parkinson Disease and Movement DisorderSociety,\n2which have an accuracy of over 90%.3Magnetic\nresonance imaging and I-123 single-photon emission com-putedtomographyscansareoccasionallyusedtodistinguishPD from rarer causes of parkinsonism but are frequently notperformed\n4andthereisnoroleformagneticresonanceangi-\nography in diagnosing PD. The 2 measures of PD severityin this study are even simpler. Hoehn and Yahr stage is a5-point scale that grades functional disability based onwhether a person’s symptoms are unilateral or bilateral andwhether they can walk with or without assistance. It can begleaned from watching someone walk down a hallway for 10seconds. The Unified Parkinson’s Disease Rating Scale is astandardized neurologic examination that takes about 10minutes to perform. Training is available online through theInternational Parkinson Disease and Movement DisorderSocietywebsiteandnonphysicianresearchershaveadminis-tered it as part of population-based studies, such as theAging, Demographics, and Memory Study.\nFundusphotographyisrapidandefficient,butspeedalone\nshould not justify developing an imperfect (and potentiallycostly)surrogatewhenthegoldstandardisalreadyeasytomea-sure. That PD severity can be predicted from retinal photo-graphs at all is remarkable and the authors\n1should be con-\ngratulatedonthisachievement.Butasitstands,thisworkfeelslike a solution in search of a problem. As a movement disor-dersspecialist,IhavenotwishedforabetterwaytodiagnoseLetters\njamaophthalmology.com (Reprinted) JAMA Ophthalmology September 2023 Volume 141, Number 9 911\n© 2023 American Medical Association. All rights reserved.\nDownloaded from jamanetwork.com by",
            "page": 0
        },
        "id": "1586"
    },
    {
        "document": "International Parkinson Disease and Movement Disorder Society",
        "metadata": {
            "originalPdf": "d632f53d-16aa-4d0b-b227-350055d6609c.pdf",
            "originalText": "ents . 4th ed. American Academy\nof Pediatrics; 2017. doi: 10.1542/9781610020237\n2. Marsh-Tootle WL, Wall TC, Tootle JS, Person SD, Kristofco RE. Quantitative\npediatric vision screening in primary care settings in Alabama. Optom Vis Sci .\n2008;85(9):849-856. doi: 10.1097/OPX.0b013e318185282a3. Health Resources and Services Administration. Children with special health\ncare needs. NSCH Data Brief. July 2020. Accessed June 14, 2023. https://mchb.\nhrsa.gov/sites/default/files/mchb/programs-impact/nsch-cshcn-data-brief.pdf\n4. Ma X, Zhou Z, Yi H, et al. Effect of providing free glasses on children’s\neducational outcomes in China: cluster randomized controlled trial. BMJ. 2014;\n349:g5740. doi: 10.1136/bmj.g5740\n5. Muhammad M, Tumin D. Unmet needs for vision care among children with\ngaps in health insurance coverage. J AAPOS . 2022;26(2):63.e1-63.e4.\ndoi:10.1016/j.jaapos.2021.12.005\n6. US Department of Health and Human Services. Children’s health coverage\ntrends: gains in 2020-2022 reverse previous coverage losses. Accessed June 14.2023. https://aspe.hhs.gov/sites/default/files/documents/\n77d7cc41648a371e0b5128f0dec2470e/aspe-childrens-health-coverage.pdf .\nCOMMENT & RESPONSE\nDeep Learning, the Retina,\nand Parkinson Disease\nTo the Editor IreadwithinterestthearticlebyAhnetal1onthe\napplication of deep-learning algorithms to retinal photo-graphsinParkinsondisease(PD).Whileitisintriguingthatadeep-learningalgorithmcanpredictthepresenceandsever-ity of PD with 65% to 75% accuracy, the broader motivationandpracticalapplicationsforthisworkareunclear.\nThe authors\n1write that complex neurologic tests are\nrequired to diagnose PD, and therefore, new diagnostic testsare needed. This is true only insomuch as taking a historyand performing a neurologic examination are consideredcomplex. PD is a clinical diagnosis for which no imaging orlaboratory testing is required. Brain imaging is frequentlyincorporated into research studies but is not required for aclinical diagnosis according to diagnostic criteria from theInternational Parkinson Disease and Movement DisorderSociety,\n2which have an accuracy of over 90%.3Magnetic\nresonance imaging and I-123 single-photon emission com-putedtomographyscansareoccasionallyusedtodistinguishPD from rarer causes of parkinsonism but are frequently notperformed\n4andthereisnoroleformagneticresonanceangi-\nography in diagnosing PD. The 2 measures of PD severityin this study are even simpler. Hoehn and Yahr stage is a5-point scale that grades functional disability based onwhether a person’s symptoms are unilateral or bilateral andwhether they can walk with or without assistance. It can begleaned from watching someone walk down a hallway for 10seconds. The Unified Parkinson’s Disease Rating Scale is astandardized neurologic examination that takes about 10minutes to perform. Training is available online through theInternational Parkinson Disease and Movement DisorderSocietywebsiteandnonphysicianresearchershaveadminis-tered it as part of population-based studies, such as theAging, Demographics, and Memory Study.\nFundusphotographyisrapidandefficient,butspeedalone\nshould not justify developing an imperfect (and potentiallycostly)surrogatewhenthegoldstandardisalreadyeasytomea-sure. That PD severity can be predicted from retinal photo-graphs at all is remarkable and the authors\n1should be con-\ngratulatedonthisachievement.Butasitstands,thisworkfeelslike a solution in search of a problem. As a movement disor-dersspecialist,IhavenotwishedforabetterwaytodiagnoseLetters\njamaophthalmology.com (Reprinted) JAMA Ophthalmology September 2023 Volume 141, Number 9 911\n© 2023 American Medical Association. All rights reserved.\nDownloaded from jamanetwork.com by",
            "page": 0
        },
        "id": "3236"
    },
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "02.Deep Learning Using Images of the Retina.pdf",
            "originalText": "HAL Id: hal-04036382\nhttps://hal.science/hal-04036382\nSubmitted on 23 Apr 2023\nHAL is a multi-disciplinary open access\narchive for the deposit and dissemination of sci-\nentific research documents, whether they are pub-\nlished or not. The documents may come from\nteaching and research institutions in F rance or\nabroad, or from public or private research centers.L’archive ouverte pluridisciplinaire HAL , est\ndestinée au dépôt et à la diffusion de documents\nscientifiques de niveau recherche, publiés ou non,\némanant des établissements d’enseignement et de\nrecherche français ou étrangers, des laboratoires\npublics ou privés.\nDeep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in\nParkinson Disease\nJanan Arslan, Daniel Racoceanu, Kurt K Benke\nT o cite this version:\nJanan Arslan, Daniel Racoceanu, Kurt K Benke. Deep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in Parkinson Disease. JAMA Ophthalmology ,\n2023, 141 (3), pp.240-241. ￿10.1001/jamaophthalmol.2022.6036￿. ￿hal-04036382￿",
            "page": 0
        },
        "id": "3579"
    },
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "02.Deep Learning Using Images of the Retina.pdf",
            "originalText": "HAL Id: hal-04036382\nhttps://hal.science/hal-04036382\nSubmitted on 23 Apr 2023\nHAL is a multi-disciplinary open access\narchive for the deposit and dissemination of sci-\nentific research documents, whether they are pub-\nlished or not. The documents may come from\nteaching and research institutions in F rance or\nabroad, or from public or private research centers.L’archive ouverte pluridisciplinaire HAL , est\ndestinée au dépôt et à la diffusion de documents\nscientifiques de niveau recherche, publiés ou non,\némanant des établissements d’enseignement et de\nrecherche français ou étrangers, des laboratoires\npublics ou privés.\nDeep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in\nParkinson Disease\nJanan Arslan, Daniel Racoceanu, Kurt K Benke\nT o cite this version:\nJanan Arslan, Daniel Racoceanu, Kurt K Benke. Deep Learning Using Images of the Retina for\nAssessment of Severity of Neurological Dysfunction in Parkinson Disease. JAMA Ophthalmology ,\n2023, 141 (15), pp.240-241. ￿10.1001/jamaophthalmol.2022.6036￿. ￿hal-04036382￿",
            "page": 1
        },
        "id": "3589"
    },
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "02.Deep Learning Using Images of the Retina.pdf",
            "originalText": "Invited Commentary\nDeep Learning Using Images of the Retina for Assessment of Severity of\nNeurological Dysfunction in Parkinson Disease\nJanan Arslan, MSc, MBiostat, PhD; Daniel Racoceanu, PhD; Kurt K. Benke, PhD\nThe deep learning (DL) approach is a recent development in\nresearchontheautomationofmedicaldiagnosticsusingma-\nchinelearning.Thistypeofstatisticallearningisnotbasedon\nbiophysical(mechanistic)modelsbutontraining(forparam-\neter estimation) using a\nsample of population data.\nThereareissuesaboutrobust-\nnessinperformancewhentestingonnewdatasetsinuncon-\ntrolledconditionsseparatefromvalidationexperiments.The\nuseofDLindiagnosticmodelinghasbeendemonstratedinre-\ncentyearswithveryencouragingresultsintheassessmentof\ndiabeticretinopathy,geographicatrophyinage-relatedmacu-\nlardegeneration,andcardiovasculardiseasewhenusingim-\nagesoftheretina.1\nThestudybyAhnetal1inthisissueof JAMA Ophthalmol-\nogyprovidesinsightsandusefulinformationontheapplica-\ntion of DL to explore possible associations between changes\nin the retina and brain function. The reported work is inter-\nestingasitexplorestheuseofDLapproachesforassessment\nofcognitivefunctionscoresfordiseaseseverityinthecaseof\nParkinsondisease(PD),whichisprojectedtobeanincreasing\neconomicburden.2Inthestudy,fundusphotographswerecol-\nlectedfrom615participantswhowereoutpatientsattheneu-\nrologydepartmentofKangbukSamsungHospitalinSouthKo-\nrea(August2020toApril2021).Tocompensateforthetypically\nsmall sample sizes often encountered in ophthalmology re-\nsearch, the authors applied a range of image augmentation\ntechniques,whichincludedrandomrotationandrandomflip,\ntoincreasethesamplesize.\nFivecommonconvolutionalneuralnetwork(CNN)mod-\nelswereinvestigatedtopredicttheHoehnandYahrScale(H-Y)\nandUnifiedParkinson’sDiseaseRatingScalepartIII(UPDRS)\nscores for PD,3,4with the training based on fundus photo-\ngraphs and patient demographic characteristics. The study\nechoed other works that have investigated the idea that\nchangesmanifestedintheretinamayprovideindicatorsofneu-\nrological impairment due to PD.5The prospective case-\ncontrolhospital-basedstudyrevealedthat,fortheinternalvali-\ndationdata,theDLsystemhadhighsensitivitythatwasabove\n80%forboththeH–YandUPDRSscores.Thespecificityranged\nfrom66%to67%forH-YandUPDRSscores.Fortheexternal\nvalidationdata,thesensitivityandspecificitywere70.73%and\n66.66%.Theareaunderthereceiveroperatingcharacteristic\ncurvewas0.67andaccuracywas70.5%.\nAnadvantageofthismethodforseverityassessmentisthat\nitisnoninvasiveandbasedonreadilyavailablefundusretina\nimages,ratherthanusingimagesofthebrain,suchasradio-\nlogicalimageslikecomputedtomographyandmagneticreso-\nnanceimagingscans.Comparatively,theseimagesarealittle\nmoreinvasiveandtimeconsumingintheiracquisition.Anad-\nditional salient feature of this study was that it suggests thepossibility of augmenting or even eventually replacing the 2\nstandard tests for severity of PD dysfunction, which are rat-\ning scales with a subjective component, with a more objec-\ntive approach that reduces risk and uncertainty in diagnosis\nand therefore improves reliability. An approach based on DL\nmaybeusedasafastscreeningmethodforcognitiveimpair-\nmentduringroutineeyeexaminations.Afeatureofthediag-\nnostic method is that finding an association between the al-\ngorithm prediction and the results for the 2 standard tests\nprovides a degree of “explainability.” This is because the DL\nalgorithmusedtodevelopthepredictivemodelproducesre-\nsultsthatareassociatedwithadiseaseseverityscale.Further-\nmore,",
            "page": 2
        },
        "id": "3598"
    },
    {
        "document": "Unified Parkinson’s Disease Rating Scale",
        "metadata": {
            "originalPdf": "02.Deep Learning Using Images of the Retina.pdf",
            "originalText": "Invited Commentary\nDeep Learning Using Images of the Retina for Assessment of Severity of\nNeurological Dysfunction in Parkinson Disease\nJanan Arslan, MSc, MBiostat, PhD; Daniel Racoceanu, PhD; Kurt K. Benke, PhD\nThe deep learning (DL) approach is a recent development in\nresearchontheautomationofmedicaldiagnosticsusingma-\nchinelearning.Thistypeofstatisticallearningisnotbasedon\nbiophysical(mechanistic)modelsbutontraining(forparam-\neter estimation) using a\nsample of population data.\nThereareissuesaboutrobust-\nnessinperformancewhentestingonnewdatasetsinuncon-\ntrolledconditionsseparatefromvalidationexperiments.The\nuseofDLindiagnosticmodelinghasbeendemonstratedinre-\ncentyearswithveryencouragingresultsintheassessmentof\ndiabeticretinopathy,geographicatrophyinage-relatedmacu-\nlardegeneration,andcardiovasculardiseasewhenusingim-\nagesoftheretina.1\nThestudybyAhnetal1inthisissueof JAMA Ophthalmol-\nogyprovidesinsightsandusefulinformationontheapplica-\ntion of DL to explore possible associations between changes\nin the retina and brain function. The reported work is inter-\nestingasitexplorestheuseofDLapproachesforassessment\nofcognitivefunctionscoresfordiseaseseverityinthecaseof\nParkinsondisease(PD),whichisprojectedtobeanincreasing\neconomicburden.2Inthestudy,fundusphotographswerecol-\nlectedfrom615participantswhowereoutpatientsattheneu-\nrologydepartmentofKangbukSamsungHospitalinSouthKo-\nrea(August2020toApril2021).Tocompensateforthetypically\nsmall sample sizes often encountered in ophthalmology re-\nsearch, the authors applied a range of image augmentation\ntechniques,whichincludedrandomrotationandrandomflip,\ntoincreasethesamplesize.\nFivecommonconvolutionalneuralnetwork(CNN)mod-\nelswereinvestigatedtopredicttheHoehnandYahrScale(H-Y)\nandUnifiedParkinson’sDiseaseRatingScalepartIII(UPDRS)\nscores for PD,3,4with the training based on fundus photo-\ngraphs and patient demographic characteristics. The study\nechoed other works that have investigated the idea that\nchangesmanifestedintheretinamayprovideindicatorsofneu-\nrological impairment due to PD.5The prospective case-\ncontrolhospital-basedstudyrevealedthat,fortheinternalvali-\ndationdata,theDLsystemhadhighsensitivitythatwasabove\n80%forboththeH–YandUPDRSscores.Thespecificityranged\nfrom66%to67%forH-YandUPDRSscores.Fortheexternal\nvalidationdata,thesensitivityandspecificitywere70.73%and\n66.66%.Theareaunderthereceiveroperatingcharacteristic\ncurvewas0.67andaccuracywas70.5%.\nAnadvantageofthismethodforseverityassessmentisthat\nitisnoninvasiveandbasedonreadilyavailablefundusretina\nimages,ratherthanusingimagesofthebrain,suchasradio-\nlogicalimageslikecomputedtomographyandmagneticreso-\nnanceimagingscans.Comparatively,theseimagesarealittle\nmoreinvasiveandtimeconsumingintheiracquisition.Anad-\nditional salient feature of this study was that it suggests thepossibility of augmenting or even eventually replacing the 2\nstandard tests for severity of PD dysfunction, which are rat-\ning scales with a subjective component, with a more objec-\ntive approach that reduces risk and uncertainty in diagnosis\nand therefore improves reliability. An approach based on DL\nmaybeusedasafastscreeningmethodforcognitiveimpair-\nmentduringroutineeyeexaminations.Afeatureofthediag-\nnostic method is that finding an association between the al-\ngorithm prediction and the results for the 2 standard tests\nprovides a degree of “explainability.” This is because the DL\nalgorithmusedtodevelopthepredictivemodelproducesre-\nsultsthatareassociatedwithadiseaseseverityscale.Further-\nmore,",
            "page": 2
        },
        "id": "3600"
    },
    {
        "document": "Parkinson's disease",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": "otheneurologicdysfunctionamongPDpatientsbyprovidinginformationonhowtoapplyadeeplearningmethodtoevaluatetheassociationbetweentheretinaandbrain.StudydatamayhelpclarifyrecentresearchfindingsregardingdopaminepathologiccascadesbetweentheretinaandbrainamongpatientswithPD;h owever,fur therresearchisneededtoexpand\ntheclinicalimplicationofthisalgorithm.\nJAMA Ophthalmol .2023;141(3):234-240.doi: 10.1001/jamaophthalmol.2022.5928\nPublishedonlineFebruary9,2023.Invited Commentary\npage240\nSupplemental content\nAuthor Affiliations: Author\naffiliationsarelistedattheendofthisarticle.\nCorresponding Authors: WonTae\nYoon,MD,PhD,DepartmentofNeurology,KangbukSamsungHospital,SungkyunkwanUniversitySchoolofMedicine,29Saemunan-Ro,Jongno-Gu,Seoul03181,SouthKorea( wtyoon@gmail.\ncom);JitaeShin,PhD,Departmentof\nElectricalandComputerEngineering,SungkyunkwanUniversity,2066,Seobu-Ro,Jangan-Gu,Suwon16419,SouthKorea( jtshin@skku.edu ).Research\nJAMA Ophthalmology | Original Investigation\n234 (Reprinted) jamaophthalmology.com\n© 2023 American Medical Association. All rights reserved.\nDownloaded from jamanetwork.com by Kyungpook National University user on 01/10/2024",
            "page": 0
        },
        "id": "4452"
    },
    {
        "document": "Parkinson disease (PD)",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": "Parkinson disease (PD) is the second most common\nneurodegenerative disorder, and, owing to the agingpopulation, the number of patients with PD is\nexpected to double by 2030.\n1Projected PD prevalence will\nbe more than 1.6 million in the US with projected total eco-nomic burden surpassing $79 billion by 2037.\n2The diagno-\nsisofPDisbasedontheclinicalmanifestationsandfindingsfrom complex neuroimaging examinations, such as mag-netic resonance imaging (MRI) or magnetic resonance angi-ography (MRA), which contribute to medical burden amongpatients with PD. Therefore, besides the established diag-nostic method, many studies have been conducted to inves-tigate the potential metrics for PD, translating these intoclinically practical tools for the diagnosis and treatment ofpatients with PD.\nThe unique features of the retina make it a useful\nassessment tool for various systemic diseases. First, theretina is the only organ in which blood vessels can be exam-ined noninvasively. Recently, in addition to predicting bio-metric data associated with cardiovascular risks, attemptsto assess the direct cardiovascular disease risk by predictingthe coronary calcium score based on fundus photographshave been made by several studies; these attempts haveyielded encouraging results.\n3-7Cho et al7reported predict-\ning coronary calcium score based on the fundus photo-graphs with other biometrics showing an area under thereceiver operating characteristic curve (AUROC) of 0.757(95% CI, 0.73-0.79). Second, due to a common embryonicorigin, the brain and retina share many biological featuresthatplayaprominentroleinthepathogenesisofmajorneu-rodegenerative diseases, including PD.\n8-18Recent studies\nhave reported that PD progression is associated with thestructural changes in the retinal nerve fiber layer and sug-gest the potential role of the retina as a modality for assess-ing PD progression.\n16-21Recently, deep learning algorithms\nhave been used in several medical fields. Even though deeplearningalgorithmsareconsideredblackboxlearningmeth-ods (ie, the machine learning model provides a result with-out explaining how that result was derived), these algo-rithms permit clinicians to seek new associations andfindings that are beyond the extent of traditional analyticmethods and human participants.\n1-5The application of vari-\nousdeeplearningmethodstopredictcardiovasculardiseaserisks or systemic biometric values using fundus photogra-phy is already well known.\n6,7Given the strong anatomic\nassociation between the retina and PD, it is natural forresearchers of PD to study the possible role of fundus pho-tographs using the Hoehn and Yahr (H-Y) scale and UnifiedParkinson’s Disease Rating Scale part III (UPDRS-III) evalua-tion metric. Therefore, in this prospective study, we devel-opedadeeplearningalgorithmtopredictboththeH-Yscaleand UPDRS-III score using fundus photography amongpatients with PD. Moreover, heat maps were evaluated inthe macular area to confirm the anatomic association of ouralgorithm’s function. Furthermore, external validation forthe assessment function of this algorithm was conductedusing 2 independent hospital data sets to test the functionof our algorithm in different clinical settings.Methods\nStudy Design and Participants\nThisdecisionanalyticalmodel,conductedfromMay1toSep-tember 30, 2021, adheres to the tenets of the Declaration ofHelsinki. The study protocol was reviewed and approved bytheinstitutionalreviewboardofKangbukSamsungHospital.Except for the fundus photographs used for external valida-tion,allparticipants’writteninformedconsentwasacquiredforthisstudy.ThisstudyfollowedtheConsolidatedHealthEco-nomic Evaluation Reporting Standards ( CHEERS ) reporting\nguidelines.\nFor external validation, we used the fundus photo-\ngraphs of patients with PD who visited the ophthalmologydepartment of Seoul National University Hospital andYeungnam University Hospital. Patients with PD wererecruitedfromtheMovementDisordersClinicoftheneurol-ogy department of Kangbuk Samsung Hospital from Octo-ber 7, 2020, to April 30, 2021. A movement disorders spe-cialist (W.T.Y.) determined the PD diagnosis based on theclinical diagnostic criteria of the UK PD Brain Bank Society’sbrain imaging study, which used brain MRI and MRA andfluoro-propyl-carbomethoxy-iodophenyl",
            "page": 1
        },
        "id": "4456"
    },
    {
        "document": "Unified Parkinson’s Disease Rating Scale part III (UPDRS-III)",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": "Parkinson disease (PD) is the second most common\nneurodegenerative disorder, and, owing to the agingpopulation, the number of patients with PD is\nexpected to double by 2030.\n1Projected PD prevalence will\nbe more than 1.6 million in the US with projected total eco-nomic burden surpassing $79 billion by 2037.\n2The diagno-\nsisofPDisbasedontheclinicalmanifestationsandfindingsfrom complex neuroimaging examinations, such as mag-netic resonance imaging (MRI) or magnetic resonance angi-ography (MRA), which contribute to medical burden amongpatients with PD. Therefore, besides the established diag-nostic method, many studies have been conducted to inves-tigate the potential metrics for PD, translating these intoclinically practical tools for the diagnosis and treatment ofpatients with PD.\nThe unique features of the retina make it a useful\nassessment tool for various systemic diseases. First, theretina is the only organ in which blood vessels can be exam-ined noninvasively. Recently, in addition to predicting bio-metric data associated with cardiovascular risks, attemptsto assess the direct cardiovascular disease risk by predictingthe coronary calcium score based on fundus photographshave been made by several studies; these attempts haveyielded encouraging results.\n3-7Cho et al7reported predict-\ning coronary calcium score based on the fundus photo-graphs with other biometrics showing an area under thereceiver operating characteristic curve (AUROC) of 0.757(95% CI, 0.73-0.79). Second, due to a common embryonicorigin, the brain and retina share many biological featuresthatplayaprominentroleinthepathogenesisofmajorneu-rodegenerative diseases, including PD.\n8-18Recent studies\nhave reported that PD progression is associated with thestructural changes in the retinal nerve fiber layer and sug-gest the potential role of the retina as a modality for assess-ing PD progression.\n16-21Recently, deep learning algorithms\nhave been used in several medical fields. Even though deeplearningalgorithmsareconsideredblackboxlearningmeth-ods (ie, the machine learning model provides a result with-out explaining how that result was derived), these algo-rithms permit clinicians to seek new associations andfindings that are beyond the extent of traditional analyticmethods and human participants.\n1-5The application of vari-\nousdeeplearningmethodstopredictcardiovasculardiseaserisks or systemic biometric values using fundus photogra-phy is already well known.\n6,7Given the strong anatomic\nassociation between the retina and PD, it is natural forresearchers of PD to study the possible role of fundus pho-tographs using the Hoehn and Yahr (H-Y) scale and UnifiedParkinson’s Disease Rating Scale part III (UPDRS-III) evalua-tion metric. Therefore, in this prospective study, we devel-opedadeeplearningalgorithmtopredictboththeH-Yscaleand UPDRS-III score using fundus photography amongpatients with PD. Moreover, heat maps were evaluated inthe macular area to confirm the anatomic association of ouralgorithm’s function. Furthermore, external validation forthe assessment function of this algorithm was conductedusing 2 independent hospital data sets to test the functionof our algorithm in different clinical settings.Methods\nStudy Design and Participants\nThisdecisionanalyticalmodel,conductedfromMay1toSep-tember 30, 2021, adheres to the tenets of the Declaration ofHelsinki. The study protocol was reviewed and approved bytheinstitutionalreviewboardofKangbukSamsungHospital.Except for the fundus photographs used for external valida-tion,allparticipants’writteninformedconsentwasacquiredforthisstudy.ThisstudyfollowedtheConsolidatedHealthEco-nomic Evaluation Reporting Standards ( CHEERS ) reporting\nguidelines.\nFor external validation, we used the fundus photo-\ngraphs of patients with PD who visited the ophthalmologydepartment of Seoul National University Hospital andYeungnam University Hospital. Patients with PD wererecruitedfromtheMovementDisordersClinicoftheneurol-ogy department of Kangbuk Samsung Hospital from Octo-ber 7, 2020, to April 30, 2021. A movement disorders spe-cialist (W.T.Y.) determined the PD diagnosis based on theclinical diagnostic criteria of the UK PD Brain Bank Society’sbrain imaging study, which used brain MRI and MRA andfluoro-propyl-carbomethoxy-iodophenyl",
            "page": 1
        },
        "id": "4468"
    },
    {
        "document": "Movement Disorders Clinic",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": "Parkinson disease (PD) is the second most common\nneurodegenerative disorder, and, owing to the agingpopulation, the number of patients with PD is\nexpected to double by 2030.\n1Projected PD prevalence will\nbe more than 1.6 million in the US with projected total eco-nomic burden surpassing $79 billion by 2037.\n2The diagno-\nsisofPDisbasedontheclinicalmanifestationsandfindingsfrom complex neuroimaging examinations, such as mag-netic resonance imaging (MRI) or magnetic resonance angi-ography (MRA), which contribute to medical burden amongpatients with PD. Therefore, besides the established diag-nostic method, many studies have been conducted to inves-tigate the potential metrics for PD, translating these intoclinically practical tools for the diagnosis and treatment ofpatients with PD.\nThe unique features of the retina make it a useful\nassessment tool for various systemic diseases. First, theretina is the only organ in which blood vessels can be exam-ined noninvasively. Recently, in addition to predicting bio-metric data associated with cardiovascular risks, attemptsto assess the direct cardiovascular disease risk by predictingthe coronary calcium score based on fundus photographshave been made by several studies; these attempts haveyielded encouraging results.\n3-7Cho et al7reported predict-\ning coronary calcium score based on the fundus photo-graphs with other biometrics showing an area under thereceiver operating characteristic curve (AUROC) of 0.757(95% CI, 0.73-0.79). Second, due to a common embryonicorigin, the brain and retina share many biological featuresthatplayaprominentroleinthepathogenesisofmajorneu-rodegenerative diseases, including PD.\n8-18Recent studies\nhave reported that PD progression is associated with thestructural changes in the retinal nerve fiber layer and sug-gest the potential role of the retina as a modality for assess-ing PD progression.\n16-21Recently, deep learning algorithms\nhave been used in several medical fields. Even though deeplearningalgorithmsareconsideredblackboxlearningmeth-ods (ie, the machine learning model provides a result with-out explaining how that result was derived), these algo-rithms permit clinicians to seek new associations andfindings that are beyond the extent of traditional analyticmethods and human participants.\n1-5The application of vari-\nousdeeplearningmethodstopredictcardiovasculardiseaserisks or systemic biometric values using fundus photogra-phy is already well known.\n6,7Given the strong anatomic\nassociation between the retina and PD, it is natural forresearchers of PD to study the possible role of fundus pho-tographs using the Hoehn and Yahr (H-Y) scale and UnifiedParkinson’s Disease Rating Scale part III (UPDRS-III) evalua-tion metric. Therefore, in this prospective study, we devel-opedadeeplearningalgorithmtopredictboththeH-Yscaleand UPDRS-III score using fundus photography amongpatients with PD. Moreover, heat maps were evaluated inthe macular area to confirm the anatomic association of ouralgorithm’s function. Furthermore, external validation forthe assessment function of this algorithm was conductedusing 2 independent hospital data sets to test the functionof our algorithm in different clinical settings.Methods\nStudy Design and Participants\nThisdecisionanalyticalmodel,conductedfromMay1toSep-tember 30, 2021, adheres to the tenets of the Declaration ofHelsinki. The study protocol was reviewed and approved bytheinstitutionalreviewboardofKangbukSamsungHospital.Except for the fundus photographs used for external valida-tion,allparticipants’writteninformedconsentwasacquiredforthisstudy.ThisstudyfollowedtheConsolidatedHealthEco-nomic Evaluation Reporting Standards ( CHEERS ) reporting\nguidelines.\nFor external validation, we used the fundus photo-\ngraphs of patients with PD who visited the ophthalmologydepartment of Seoul National University Hospital andYeungnam University Hospital. Patients with PD wererecruitedfromtheMovementDisordersClinicoftheneurol-ogy department of Kangbuk Samsung Hospital from Octo-ber 7, 2020, to April 30, 2021. A movement disorders spe-cialist (W.T.Y.) determined the PD diagnosis based on theclinical diagnostic criteria of the UK PD Brain Bank Society’sbrain imaging study, which used brain MRI and MRA andfluoro-propyl-carbomethoxy-iodophenyl",
            "page": 1
        },
        "id": "4472"
    },
    {
        "document": "Unified Parkinson’s Disease Rating Scale (UPDRS)",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": " 59.44 (57.46-61.42) 0.72 (0.70-0.73) 63.55 (61.58-65.53)\n4d83.23 (82.07-84.38) 66.81 (64.97-68.65) 0.77 (0.75-0.79) 73.38 (71.55-75.21)\nAbbreviation:AUROC,areaunderthereceiveroperatingcharacteristiccurve.\naModel1:fundusonly.\nbModel2:funduswithsexandagedata.cModel3:funduswithsex,age,diabetes,andhypertensiondata.\ndModel4:fundusimagewithsex,age,diabetes,andhypertensiondatawith\nmultimodalmethod.\nTable 3. Unified Parkinson’s Disease Rating Scale (UPDRS) Prediction Results of the Deep Learning System\nModel% (95% CI)\nAUROC (95% CI) Accuracy, % (95% CI) Sensitivity Specificity\n1a77.16 (75.52-78.81) 54.75 (51.96-57.53) 0.67 (0.65-0.69) 59.43 (57.83-61.03)\n2b78.93 (77.84-80.03) 57.67 (55.68-59.66) 0.69 (0.68-0.71) 62.24 (60.43-64.05)\n3c79.54 (77.91-81.17) 59.21 (55.81-62.60) 0.70 (0.69-0.72) 65.31 (63.61-67.01)\n4d82.61 (81.38-83.83) 65.75 (62.56-68.94) 0.77 (0.75-0.79) 71.64 (70.19-73.09)\nAbbreviation:AUROC,areaunderthereceiveroperatingcharacteristiccurve.\naModel1:fundusonly.\nbModel2:funduswithsexandagedata.cModel3:funduswithsex,age,diabetes,andhypertensiondata.\ndModel4:fundusimagewithsex,age,diabetes,andhypertensiondatawith\nmultimodalmethod.Research Original Investigation NeurologicDysfunctionAssessmentinParkinsonDiseaseBasedonFundusPhotographsUsingDeepLearning\n238 JAMA Ophthalmology March2023 Volume141,Number3 (Reprinted) jamaophthalmology.com\n© 2023 American Medical Association. All rights reserved.\nDownloaded from jamanetwork.com by Kyungpook National University user on 01/10/2024",
            "page": 4
        },
        "id": "4487"
    },
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": ",KopilC,etal.Currentand\nprojectedfutureeconomicburdenofParkinsondiseaseintheU.S. NPJ Parkinsons Dis .2020;6:15.\ndoi:10.1038/s41531-020-0117-1\n3. FetitAE,DoneyAS,HoggS,etal.Amultimodal\napproachtocardiovascularriskstratificationinpatientswithtype2diabetesincorporatingretinal,genomic, and clinical features. Sci Rep. 2019;9(1):\n3591.doi: 10.1038/s41598-019-40403-1\n4. RheeEJ,ChungPW,WongTY,SongSJ.\nRelationshipofretinalvascularcalibervariationwithintracranialarterialstenosis. Microvasc Res .\n2016;108:64-68.doi: 10.1016/j.mvr.2016.08.002NeurologicDysfunctionAssessmentinParkinsonDiseaseBasedonFundusPhotographsUsingDeepLearning Original Investigation Research\njamaophthalmology.com (Reprinted) JAMA Ophthalmology March2023 Volume141,Number3 239\n© 2023 American Medical Association. All rights reserved.\nDownloaded from jamanetwork.com by Kyungpook National University user on 01/10/2024",
            "page": 5
        },
        "id": "4502"
    },
    {
        "document": "Parkinson Disease",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": "ocularfundusphotographs. Neurology .2021;97(4):e369-\ne377.doi: 10.1212/WNL.0000000000012226\n26. Scikit-learn.Homepage.AccessedApril5,\n2022.https://scikit-learn.org/stable/\nInvited Commentary\nDeep Learning Using Images of the Retina for Assessment of Severity\nof Neurological Dysfunction in Parkinson Disease\nJananArslan,MSc,MBiostat,PhD;DanielRacoceanu,PhD;KurtK.Benke,PhD\nThe deep learning (DL) approach isarecentdevelopmentin\nresearchontheautomationofmedicaldiagnosticsusingma-chinelearning.Thistypeofstatisticallearningisnotbasedon\nbiophysical (mechanistic)models but on training (forparameterestimation)usingasample of population data.\nThereareissuesaboutrobustnessinperformancewhentest-ingonnewdatasetsinuncontrolledconditionsseparatefromvalidation experiments. The use of DL in diagnostic model-inghasbeendemonstratedinrecentyearswithveryencour-aging results in the assessment of diabetic retinopathy, geo-graphic atrophy in age-related macular degeneration, andcardiovasculardiseasewhenusingimagesoftheretina.\n1\nThestudybyAhnetal1inthisissueof JAMA Ophthalmology\nprovidesinsightsandusefulinformationontheapplicationofDLtoexplorepossibleassociationsbetweenchangesintheretinaandbrainfunction.ThereportedworkisinterestingasitexplorestheuseofDLapproachesforassessmentofcognitivefunctionscoresfordiseaseseverityinthecaseofParkinsondisease(PD),whichisprojectedtobeanincreasingeconomicburden.\n2Inthe\nstudy,fundusphotographswerecollectedfrom615participantswhowereoutpatientsattheneurologydepartmentofKangbukSamsungHospitalinSouthKorea(August2020toApril2021).Tocompensateforthetypicallysmallsamplesizesoftenencoun-teredinophthalmologyresearch,theauthorsappliedarangeofimageaugmentationtechniques,whichincludedrandomrota-tionandrandomflip,toincreasethesamplesize.\nFivecommonconvolutionalneuralnetwork(CNN)mod-\nelswereinvestigatedtopredicttheHoehnandYahrScale(H-Y)andUnifiedParkinson’sDiseaseRatingScalepartIII(UPDRS)scores for PD,\n3,4with the training based on fundus photo-\ngraphs and patient demographic characteristics. The studyechoed other works that have investigated the idea thatchanges manifested in the retina may provide indicators ofneurological impairment due to PD.\n5The prospective case-\ncontrolhospital-basedstudyrevealedthat,fortheinternalvali-dationdata,theDLsystemhadhighsensitivitythatwasabove80%forboththeH–YandUPDRSscores.Thespecificityrangedfrom66%to67%forH-YandUPDRSscores.FortheexternalRelated article page234Research Original Investigation NeurologicDysfunctionAssessmentinParkinsonDiseaseBasedonFundusPhotographsUsingDeepLearning\n240 JAMA Ophthalmology March2023 Volume141,Number3 (Reprinted) jamaophthalmology.com\n© 2023 American Medical Association. All rights reserved.\nDownloaded from jamanetwork.com by Kyungpook National University user on 01/10/2024",
            "page": 6
        },
        "id": "4506"
    },
    {
        "document": "Unified Parkinson’s Disease Rating Scale",
        "metadata": {
            "originalPdf": "01.Neurologic Dysfunction Assessment in Parkinson Disease.pdf",
            "originalText": "ocularfundusphotographs. Neurology .2021;97(4):e369-\ne377.doi: 10.1212/WNL.0000000000012226\n26. Scikit-learn.Homepage.AccessedApril5,\n2022.https://scikit-learn.org/stable/\nInvited Commentary\nDeep Learning Using Images of the Retina for Assessment of Severity\nof Neurological Dysfunction in Parkinson Disease\nJananArslan,MSc,MBiostat,PhD;DanielRacoceanu,PhD;KurtK.Benke,PhD\nThe deep learning (DL) approach isarecentdevelopmentin\nresearchontheautomationofmedicaldiagnosticsusingma-chinelearning.Thistypeofstatisticallearningisnotbasedon\nbiophysical (mechanistic)models but on training (forparameterestimation)usingasample of population data.\nThereareissuesaboutrobustnessinperformancewhentest-ingonnewdatasetsinuncontrolledconditionsseparatefromvalidation experiments. The use of DL in diagnostic model-inghasbeendemonstratedinrecentyearswithveryencour-aging results in the assessment of diabetic retinopathy, geo-graphic atrophy in age-related macular degeneration, andcardiovasculardiseasewhenusingimagesoftheretina.\n1\nThestudybyAhnetal1inthisissueof JAMA Ophthalmology\nprovidesinsightsandusefulinformationontheapplicationofDLtoexplorepossibleassociationsbetweenchangesintheretinaandbrainfunction.ThereportedworkisinterestingasitexplorestheuseofDLapproachesforassessmentofcognitivefunctionscoresfordiseaseseverityinthecaseofParkinsondisease(PD),whichisprojectedtobeanincreasingeconomicburden.\n2Inthe\nstudy,fundusphotographswerecollectedfrom615participantswhowereoutpatientsattheneurologydepartmentofKangbukSamsungHospitalinSouthKorea(August2020toApril2021).Tocompensateforthetypicallysmallsamplesizesoftenencoun-teredinophthalmologyresearch,theauthorsappliedarangeofimageaugmentationtechniques,whichincludedrandomrota-tionandrandomflip,toincreasethesamplesize.\nFivecommonconvolutionalneuralnetwork(CNN)mod-\nelswereinvestigatedtopredicttheHoehnandYahrScale(H-Y)andUnifiedParkinson’sDiseaseRatingScalepartIII(UPDRS)scores for PD,\n3,4with the training based on fundus photo-\ngraphs and patient demographic characteristics. The studyechoed other works that have investigated the idea thatchanges manifested in the retina may provide indicators ofneurological impairment due to PD.\n5The prospective case-\ncontrolhospital-basedstudyrevealedthat,fortheinternalvali-dationdata,theDLsystemhadhighsensitivitythatwasabove80%forboththeH–YandUPDRSscores.Thespecificityrangedfrom66%to67%forH-YandUPDRSscores.FortheexternalRelated article page234Research Original Investigation NeurologicDysfunctionAssessmentinParkinsonDiseaseBasedonFundusPhotographsUsingDeepLearning\n240 JAMA Ophthalmology March2023 Volume141,Number3 (Reprinted) jamaophthalmology.com\n© 2023 American Medical Association. All rights reserved.\nDownloaded from jamanetwork.com by Kyungpook National University user on 01/10/2024",
            "page": 6
        },
        "id": "4509"
    }
]